Dr. Michael Redinger is an Associate Professor at the Western Michigan University Homer Stryker M.D. School of Medicine (WMed). He is dually appointed in the Department of Medical Ethics, Humanities, and Law, for which he serves as Co-Chair, and the Department of Psychiatry. He also serves as the current Young Physician Section representative on the Michigan State Medical Society Board of Directors, as an Alternate Delegate from Michigan to the American Medical Association, and as the Inaugural Unit Head of the WMed Unit of the International Network of the UNESCO Chair in Bioethics.

His myriad of research interests include clinical ethics, psychiatric ethics, religion, and medicine, Catholic health care ethics, and medical professionalism.  He has been published in The New England Journal of Medicine, CHEST, The American Journal of Psychiatry, The American Journal of Bioethics, Cambridge Quarterly of Healthcare Ethics, and The Journal of the American Academy of Psychiatry and the Law, as well as popular media including The New York Times, the Detroit Free Press, America: The Jesuit Review, and Commonwealth magazine.

 

 

Senior Clinical Education Coordinator, Clinical Training & Education, UPMC Health Plan

 

Program Manager, Clinical Training & Education, UPMC Health Plan

 

Senior Clinical Pharmacy Specialist, Pharmacy Services, UPMC Health Plan

 

 

No planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.

 

The information presented at this CME program represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by, the UPMC Center for Continuing Education in the Health Sciences, UPMC / University of Pittsburgh Medical Center or Affiliates and University of Pittsburgh School of Medicine.  Reasonable efforts have been taken intending for educational subject matter to be presented in a balanced, unbiased fashion and in compliance with regulatory requirements. However, each program attendee must always use his/her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.